Discontinued Operations |
11. |
DISCONTINUED OPERATIONS |
The table below presents the
significant components of CSO, Group DCA’s, Pharmakon’s and TVG’s results included Income (Loss) from Discontinued
Operations, Net of Tax in the consolidated statements of comprehensive loss for the three- and six-months ended June 30, 2017 and
2016.
|
|
Three Months Ending June 30, |
|
|
Six Months Ending June 30, |
|
|
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
Revenue, net |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
1,644 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations |
|
|
304 |
|
|
|
144 |
|
|
|
914 |
|
|
|
(592 |
) |
Gain (loss) on sale of assets |
|
|
- |
|
|
|
1,326 |
|
|
|
- |
|
|
|
1,326 |
|
Income from discontinued operations, before tax |
|
|
304 |
|
|
|
1,470 |
|
|
|
914 |
|
|
|
734 |
|
Income tax expense |
|
|
358 |
|
|
|
291 |
|
|
|
412 |
|
|
|
336 |
|
(Loss) income from discontinued operations, net of tax |
|
$ |
(54 |
) |
|
$ |
1,179 |
|
|
$ |
502 |
|
|
$ |
398 |
|
The assets and liabilities
classified as discontinued operations relate to CSO, Group DCA, Pharmakon, and TVG. As of June 30, 2017 and December 31, 2016,
these assets and liabilities are in the accompanying balance sheets as follows:
For the Six Months Ended
June 30, 2017
|
|
|
For the Year Ended
December 31, 2016
|
|
|
|
|
CSO |
|
|
DCA/TVG |
|
|
Total |
|
|
CSO |
|
|
DCA/TVG |
|
|
Total |
|
Accounts receivable, net |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
Unbilled receivable, net |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Other |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
14 |
|
|
|
14 |
|
Current assets from discontinued operations |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
14 |
|
|
|
14 |
|
Property and equipment, net |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Other |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Long-term assets from discontinued operations |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Total assets |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
14 |
|
|
$ |
14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
826 |
|
|
$ |
- |
|
|
$ |
826 |
|
|
$ |
890 |
|
|
$ |
- |
|
|
$ |
890 |
|
Accrued salary and bonus |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,272 |
|
|
|
- |
|
|
|
1,272 |
|
Other |
|
|
1,545 |
|
|
|
- |
|
|
|
1,545 |
|
|
|
1,966 |
|
|
|
- |
|
|
|
1,966 |
|
Current liabilities from discontinued operations |
|
|
2,371 |
|
|
|
- |
|
|
|
2,371 |
|
|
|
4,128 |
|
|
|
- |
|
|
|
4,128 |
|
Total liabilities |
|
$ |
2,371 |
|
|
$ |
- |
|
|
$ |
2,371 |
|
|
$ |
4,128 |
|
|
$ |
- |
|
|
$ |
4,128 |
|
|